Neurocrine Biosciences (NBIX) Net Margin (2010 - 2026)
Neurocrine Biosciences (NBIX) reported Net Margin of 15.06% for Q2 2026, down 0.58 percentage points from 15.64% a year earlier and down 9.24 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Net Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Neurocrine Biosciences' Net Margin came in at 20.91%, up 7.03 percentage points year-over-year; for FY2025, it came in at 16.73%, up 2.24 percentage points from FY2024.
- Net Margin has increased for four consecutive years, though with a five-year change of -22.21 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at 14.49% in FY2024 (+1.26 pp), 13.23% in FY2023 (+2.85 pp), 10.38% in FY2022 (+2.47 pp) and 7.90% in FY2021 (-31.04 pp).
- The Q2 2026 figure ranks as the lowest quarterly Net Margin since Q1 2025.
- Year over year, Net Margin gained in five of the last eight quarters, with an average year-over-year change of +2.50 percentage points.
- The high point for year-over-year Net Margin in five years was Q3 2021 (a gain of 29.88 percentage points); the low point was Q4 2021 (a drop of 142.68 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 24.30% (Q1 2026), 19.08% (Q4 2025) and 26.36% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 32.99% |
| 10 | Neurocrine Biosciences | 14.06 Bn | 9.76 Bn | 935.80 Mn | 15.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.06% |
| Mar 31, 2026 | 24.30% |
| Dec 31, 2025 | 19.08% |
| Sep 30, 2025 | 26.36% |
| Jun 30, 2025 | 15.64% |
| Mar 31, 2025 | 1.38% |
| Dec 31, 2024 | 16.43% |
| Sep 30, 2024 | 20.86% |
| Jun 30, 2024 | 11.01% |
| Mar 31, 2024 | 8.42% |
| Dec 31, 2023 | 28.67% |
| Sep 30, 2023 | 16.66% |
| Jun 30, 2023 | 21.10% |
| Mar 31, 2023 | -18.22% |
| Dec 31, 2022 | 21.60% |
| Sep 30, 2022 | 17.66% |
| Jun 30, 2022 | -4.47% |
| Mar 31, 2022 | 4.48% |
| Dec 31, 2021 | -2.34% |
| Sep 30, 2021 | 7.60% |
API Access
Neurocrine Biosciences Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();